Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 2,062.50
+27.90 (1.37%)
Nov 12, 2026, 3:30 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 335.14 billion as of November 12, 2026. It is the 4,621st most valuable company in the world and the 266th biggest in India. Its market cap has increased by 54.87% in one year.
Market Cap
335.14B
Enterprise Value
353.81B
Revenue
38.40B
Global Rank
Country Rank
#266 India
PE Ratio
80.74
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 335.14B, an increase of 1,825.67%. That is a compound annual growth rate of 12.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 335.14B | 42.62% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 651.39B |
| Gland Pharma | 537.79B |
| Ipca Laboratories | 492.19B |
| Emcure Pharmaceuticals | 423.94B |
| Ajanta Pharma | 414.79B |
| Piramal Pharma | 326.07B |
| Alembic Pharmaceuticals | 202.36B |
| Alivus Life Sciences | 179.04B |